SCOR has acknowledged an arbitration award confirming the validity of retrocession treaties entered into with Covéa in June 2021. The treaties transfer 30% of the Life & Health portfolio held by SCOR's Irish entities as at December 31, 2020 to Covéa. The arbitration tribunal also awarded compensation to Covéa of USD 488.3 million. After taking into account provisions, the impact on SCOR's net results at Q2 2026 will be approximately EUR 50 million, with no negative impact on SCOR's solvency ratio and liquidity position. SCOR remains focused on executing the final year of its Forward 2026 plan.
SCOR SEArbitration award requires SCOR to pay $488.3M compensation, impacting Q2 2026 net results by ~€50M.
Arbitration award confirms validity of retrocession treaties and grants Covéa $488.3M compensation.